Accretive Health Inc., a Chicago-based provider of healthcare revenue cycle management services, has set its IPO terms to 13.33 million common shares being offered at between $14 and $16 per share. It would have an initial market cap of approximately $1.44 billion, were it to price at the high end of its range.
The company plans to trade on the NYSE under ticker symbol AH, with Goldman Sachs and Credit Suisse serving as co-lead underwriters. It reported around $510 million in 2009 revenue, compared to $398 million in 2008 revenue. Net income grew to $14.59 million in 2009.
Oak Hill Capital Partners holds a 21.7% pre-IPO ownership position. www.accretivehealth.com